4147 Share Price Performance
NT$84.20
13.90 (19.77%)
Price NT$84.20
Share PriceNT$84.20
4147 Community Narratives
There are no narratives available yet.
Recent 4147 News & Updates
No updates
TaiMed Biologics Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.77
- Gross Margin
- 38.57%
- Net Profit Margin
- -34.83%
- Debt/Equity Ratio
- 12.2%
TaiMed Biologics Inc. Competitors
About 4147
- Founded
- 2007
- Employees
- n/a
- CEO
- WebsiteView website
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. It develops and markets Trogarzo IV infusion and Trogarzo IV push, a monoclonal antibody for HIV treatment. The company is also developing TMB-365, a monoclonal antibody used for HIV treatment and prevention which has completed a phase-1 clinical trial; and TMB-365 and TMB-380 combination, a monoclonal antibody combination therapy for HIV that is in phase-1b/2a clinical trial, as well as antibody-drug conjugates, for cancer treatment. In addition, it offers contract development and manufacturing services. The company has a research and development agreement for Trogarzo TMB-355 with Genentech and Biogen Inc., and authorizes Samsung Biologics to produce TMB-355. TaiMed Biologics Inc. was incorporated in 2007 and is headquartered in Taipei City, Taiwan.
Taiwanese Market Performance
- 7 Days: -0.1%
- 3 Months: 13.5%
- 1 Year: 16.0%
- Year to Date: 1.8%
The market has been flat over the last week. Meanwhile, the market is actually up 16% over the past year. As for the next few years, earnings are expected to grow by 13% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading